Palliative sedation;Palliatieve sedatie

Nederlands Tijdschrift voor Geneeskunde

Volumn 149, Issue 9, 2005, Pages 458-461

  Verhagen, E H ^a   Hesselmann, G M ^b   Besse, T C ^c   De Graeff, A ^b  

^a Intg Kankerctr Midden Nederland   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c Van Mesos Medisch Centrum   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; DIAZEPAM; LEVOMEPROMAZINE; LORAZEPAM; MIDAZOLAM; MORPHINE; PHENOBARBITAL; PROPOFOL;

ARTICLE; CONSCIOUSNESS; DELIRIUM; DYING; DYSPNEA; EUTHANASIA; HUMAN; LIFE EXPECTANCY; NETHERLANDS; PAIN; PALLIATIVE THERAPY; SEDATION;

HUMANS; HYPNOTICS AND SEDATIVES; LIFE EXPECTANCY; PALLIATIVE CARE; TERMINAL CARE; TIME FACTORS;

EID: 14744268412     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Verhagen EH, Graeff A de, Hesselmann GM. Sedatie in de laatste levensfase. In: Graeff A de, Verhagen EH, Eliel MR, Hesselmann GM, Kroeze-Hoogendoorn GJ, redacteuren. Oncologieboek. Richtlijnen palliatieve zorg. Utrecht: Integraal Kankercentrum Midden-Nederland; 2002. p. 313-27.
2. Morita T, Tsuneto S, Shima Y. Proposed definitions for terminal sedation. Lancet 2001;358:335-6.
3. Morita T, Tsuneto S, Shima Y. Definition of sedation for symptom relief: a systematic literature review and a proposal of operational criteria. J Pain Symptom Manage 2002;24:447-53.
4. Cowan JD, Walsh D. Terminal sedation in palliative medicine - definition and review of the literature. Support Care Cancer 2001;9:403-7.
5. Fine PG. Total sedation in end-of-life care: clinical considerations. J Hosp Palliat Nurs 2001;3:81-7.
6. Krakauer EL, Penson RT, Truog RD, King LA, Chabner BA, Lynch jr TJ. Sedation for intractable distress of a dying patient: acute palliative care and the principle of double effect. Oncologist 2000;5:53-62.
7. Loewy EH. Terminal sedation, self-starvation, and orchestrating the end of life. Arch Intern Med 2001;161:329-32.
8. Hardy J. Sedation in terminally ill patients. Lancet 2000;356:1866-7.
9. Morita T, Inoue S, Chihara S. Sedation for symptom control in Japan: the importance of intermittent use and communication with family members. J Pain Symptom Manage 1996;12:32-8.
10. Wal G van der, Heide A van der, Onwuteaka-Philipsen BD, Maas PJ van der. Medische besluitvorming aan het einde van het leven; de praktijk en de toetsingsprocedure euthanasie. Utrecht: De Tijdstroom; 2003.
11. Verhagen EH, Eliel MR, Graeff A de, Teunissen SCCM. Sedatie in de laatste levensfase. Ned Tijdschr Geneeskd 1999;143:2601-3.
12. Deijck RHPD van, Rondas AALM, Berghmans RLP. Terminale sedatie bij wilsbekwame patiënten: geen overwegende morele bezwaren in de medische literatuur. Ned Tijdschr Geneeskd 2003;147:2479-83.
13. Morita T, Akechi T, Sugawara Y, Chihara S, Uchitomi Y. Practices and attitudes of Japanese oncologists and palliative care physicians concerning terminal sedation: a nationwide study. J Clin Oncol 2002;20:758-64.
14. Ondersteuningspunt Palliatieve Zorg Nijmegen. Conceptrichtlijn sedatie in de terminale fase. Nijmegen: Integraal Kankercentrum Oost; 2002.
15. Cherny NI, Portenoy RK. Sedation in the management of refractory symptoms: guidelines for evaluation and treatment. J Palliat Care 1994;10:31-8.
16. Quill TE, Byock IR. Responding to intractable terminal suffering: the role of terminal sedation and voluntary refusal of food and fluids. Ann Intern Med 2000;132:408-14.
17. Rousseau P, Ross E. Use of palliative sedation. Phoenix: Carl T. Hayden VA Medical Center; 2000.
18. Rousseau P. Existential suffering and palliative sedation: a brief commentary with a proposal for clinical guidelines. Am J Hosp Palliat Care 2001;18:151-3.
19. Cowan JD, Palmer TWP. Practical guide to palliative sedation. Curr Oncol Rep 2002;4:242-9.
20. Hawryluck E, Harvey W, Lemieux-Charles L, Singer P. Consensus guidelines on analgesia and sedation in dying intensive care unit patients. BMC Med Ethics 2002;3:3.
21. Wein S. Sedation in the imminently dying patient. Oncology (Huntingt) 2000;14:585-92.
22. Ventafridda V, Ripamonti C, de Conno F, Tamburini M, Cassileth BR. Symptom prevalence and control during cancer patients' last days of life. J Palliat Care 1990;6:7-11.
23. Fainsinger R, Miller MJ, Bruera E, Hanson J, MacEachem T. Symptom control during the last week of life on a palliative care unit. J Palliat Care 1991;7:5-11.
24. Fainsinger RL, Landman W, Hoskings M, Bruera E. Sedation for uncontrolled symptoms in a South African hospice. J Pain Symptom Manage 1998;16:145-52.
25. Fainsinger RL, de Moissac D, Mancini I, Oneschuk D. Sedation for delirium and other symptoms in terminally ill patiens in Edmonton. J Palliat Care 2000;16:5-10.
26. Fainsinger RL, Waller A, Bercovici M, Bengtson K, Landman W, Hoskings M, et al. A multicentre international study of sedation for uncontrolled symptoms in terminally ill patients. Palliat Med 2000;14:257-65.
27. Stone P, Phillips C, Spruyt O, Waight C. A comparison of the use of sedatives in a hospital support team and in a hospice. Palliat Med 1997;11:140-4.
28. Peruselli C, di Giulio P, Toscani F, Gallucci M, Brunelli C, Costantini M, et al. Home palliative care for terminal cancer patients: a survey on the final week of life. Palliat Med 1999;13:233-41.
29. Sykes N, Thorns A. Sedative use in the last week of life and the implications for end-of-life decision making. Arch Intern Med 2003;163:341-4.
30. Muller-Busch HC, Andres I, Jehser T. Sedation in palliative care - a critical analysis of 7 years experience. BMC Palliat Care 2003;2:2.
31. Bottomley DM, Hanks GW. Subcutaneous midazolam infusion in palliative care. J Pain Symptom Manage 1990;5:259-61.
32. Burke AL, Diamond PL, Hulbert J, Yeatman J, Farr EA. Terminal restlessness - its management and the role of midazolam. Med J Aust 1991;155:485-7.
33. Greene WR, Davis WH. Titrated intravenous barbiturates in the control of symptoms in patients with terminal cancer. South Med J 1991;84:332-7.
34. McNamara P, Minton M, Twycross RG. Use of midazolam in palliative care. Palliat Med 1991;5:244-9.
35. Stiefel F, Fainsinger R, Bruera E. Acute confusional states in patients with advanced cancer. J Pain Symptom Manage 1992;7:94-8.
36. McIver B, Walsh D, Nelson K. The use of chlorpromazine for symptom control in dying cancer patients. J Pain Symptom Manage 1994;9:341-5.
37. Fainsinger RL. Use of sedation by a hospital palliative care support team. J Palliat Care 1998;14:51-4.
38. Morita T, Tsunoda J, Inoue S, Chihara S. Do hospice clinicians sedate patients intending to hasten death? J Palliat Care 1999;15:20-3.
39. Morita T, Tsunoda J, Inoue S, Chihara S. Terminal sedation for existential distress. Am J Hosp Palliat Care 2000;17:189-95.
40. Chiu TY, Hu WY, Lue BH, Cheng SY, Chen CY. Sedation for refractory symptoms of terminal cancer patients in Taiwan. J Pain Symptom Manage 2001;21:467-72.
41. Soares LGL, Naylor C, Martins MA, Peixoto G. Dexmedetomidine: a new option for intractable distress in the dying. J Pain Symptom Manage 2002;24:6-8.
42. Sykes N, Thorns A. The use of opioids and sedatives at the end of life. Lancet Oncol 2003;4:312-8.
43. Chater S, Viola R, Paterson J, Jarvis V. Sedation for intractable distress in the dying - a survey of experts. Palliat Med 1998;12:255-69.
44. Shaiova L. Case presentation: 'terminal sedation' and existential distress. J Pain Symptom Manage 1998;16:403-7.
45. Sales JP. Sedation and terminal care. Eur J Palliat Care 2001;8:97-100.
46. Cheng C, Roemer-Becuwe C, Pereira J. When midazolam fails. J Pain Symptom Manage 2002;23:256-65.
47. Truog RD, Berde CB, Mitchell C, Grier HE. Barbiturates in the care of the terminally ill. N Engl J Med 1992;327:1678-82.
48. Moyle J. The use of propofol in palliative medicine. J Pain Symptom Manage 1995;10:643-6.
49. Billings JA, Block SD. Slow euthanasia. J Palliat Care 1996;12:21-30.
50. Jonquière E. 'Slow euthanasia' dus. Pallium 2002;4:24.
51. Morita T, Tsunoda J, Inoue S, Chihara S. Effects of high dose opioids and sedatives on survival in terminally ill cancer patients. J Pain Symptom Manage 2001;21:282-9.
52. Nuy M, Hogerwerf A. De verlegenheid ten aanzien van het menselijk beheer. Over de grens tussen normaal en buitengewoon medisch handelen. Tijdschr Geneeskd Ethiek 2000;10:121-5.
53. Swart SJ, Zuylen L van, Rijt CCD van der, Lieverse PJ, Graeff A de, Verhagen EH. Sterven kost tijd. Sedatie in de laatste levensfase is geen alternatief voor euthanasie. Med Contact 2003;58:910-1.
54. Sheldon T. 'Terminal sedation' different from euthanasia, Dutch ministers agree. BMJ Monthly Dutch Edition 2003;18:19.